Vancouver, British Columbia–(Newsfile Corp. – February 27, 2026) – Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “Telo Genomics“), a leader in the development of diagnostic and prognostic tests for human disease through the analysis of chromosomal telomeres, is pleased to announce that it has increased the size …
Read More »
Matribhumi Samachar English